<p>Marc Kirschner, head of the Harvard Medical School Department of Systems Biology, describes a <a href="https://hms.harvard.edu/content/transforming-drug-discovery">new initiative</a> that takes aim at the alarming slowdown in the development of new and lifesaving drugs. Plus, Professor of Genetics David Reich is studying DNA from an ancient finger bone to shed light on the dawn of humanity. Image by Martin Sorger.</p>

Marc Kirschner, head of the Harvard Medical School Department of Systems Biology, describes a new initiative that takes aim at the alarming slowdown in the development of new and lifesaving drugs. Plus, Professor of Genetics David Reich is studying DNA from an ancient finger bone to shed light on the dawn of humanity. Image by Martin Sorger.

<p>Marc Kirschner, head of the Harvard Medical School Department of Systems Biology, describes a <a href="https://hms.harvard.edu/content/transforming-drug-discovery" rel="noopener noreferrer">new initiative</a> that takes aim at the alarming slowdown in the development of new and lifesaving drugs. Plus, Professor of Genetics David Reich is studying DNA from an ancient finger bone to shed light on the dawn of humanity. Image by Martin Sorger.</p>

Transforming Drug Discovery

HMS scientists tackle a variety of important questions, ranging from how your neurons work to which genes play a role in particular diseases. Our podcast gives you the scoop on some of this work, providing context and highlighting the latest trends in medical education and biomedical research.

Share Transforming Drug Discovery

Sign up to save your podcasts

Transforming Drug Discovery

Transforming Drug Discovery